Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Demyelinating disorders
ADR ID BADD_A01193
ADR Hierarchy
17      Nervous system disorders
17.16      Demyelinating disorders
Description Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. | The first region-restricted episode of CNS inflammatory demyelination in a patient. It is usually characterized by an acute monosymptomatic presentation of the optic nerves, brainstem, or spinal cord. It may not reoccur (isolated), or it may progress to MULTIPLE SCLEROSIS. [MeSH]
MedDRA Code 10012303
MeSH ID D003711
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Demyelinating Diseases | Demyelinating Disease | Demyelinating Disorders | Demyelinating Disorder | Demyelination | Demyelinations | Clinically Isolated Syndrome, CNS Demyelinating | Clinically Isolated CNS Demyelinating Syndrome
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D02192Thalidomide
BADD_D02227Tipranavir disodium
BADD_D02230Tizanidine
BADD_D02236Tofacitinib
BADD_D02244Tolterodine
BADD_D02246Tolvaptan
BADD_D02247Topiramate
BADD_D02329Valproic acid
BADD_D02331Valsartan
BADD_D02337Varenicline
BADD_D02338Varenicline tartrate
BADD_D02342Vedolizumab
BADD_D02346Venlafaxine
BADD_D02369Voriconazole
BADD_D02392Zoledronic acid
BADD_D02403Ferrous sulfate
BADD_D02424Valaciclovir
BADD_D02426Ibandronate
BADD_D02436Atorvastatin
BADD_D02440Lisdexamfetamine
BADD_D02445Solifenacin
BADD_D02464Fingolimod
BADD_D02473Sodium chloride
BADD_D02511Siponimod
BADD_D02522Lithium citrate
The 5th Page    First    Pre   5    Total 5 Pages